Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/31/05 → 11/21/11 |
Funding
- Bristol-Myers Squibb Company (CA180-035)
Prot# CA180-035: Rndmzd 2-Arm, Mltctr, Opn-Lbl Phz 2 Study of BMS-354825 Admin'd Orally at Dose of 70mg 2x Daily or 140mg 1x Daily in Sbjts w/Chronic Myeloid Leukemia in Accelr'd Phz or in Myeloid or Lymphoid Blast Phz or w/Philadelphia Chromosome Positiv
- Tallman, Martin Stuart (PD/PI)
Project: Research project